Analyzing ACEI-Furosemide and ARB-Furosemide Drugs Combination on Hypertension and Chronic Kidney Disease Patients
DOI:
https://doi.org/10.55324/ijoms.v2i4.407Keywords:
ACEI-Furosemide, ARB-Furosemide, drugs combination, chronic kidney diseaseAbstract
The purpose of this study was to compare the efficacy of ACE-inhibitor + Furosemide and ARB + Furosemide in lowering creatinine, urea, and blood pressure in individuals with hypertension and chronic renal disease. This is a retrospective study in which data were extracted from the medical records of patients with hypertension and chronic kidney disease in the Internal Medicine Ward of the General Hospital dr. M. Jamil Padang in West Sumatera. A 2-by-3 ANOVA hypothesis test design was utilized. The hypothesis was evaluated using an alpha value of 0.05. The results demonstrated that the ARB + Furosemide combination was superior to the ACE-Inhibitor + Furosemide combination by 86.2%. In addition, this study demonstrated that the medication combinations ACE inhibitor plus furosemide and ARB plus furosemide were equally efficient in lowering creatinine, urea, and blood pressure in individuals with hypertension and chronic renal disease. The researchers found that antihypertensive medicines, including the ACE-Inhibitor + Furosemide combination and the ARB + Furosemide combination, can be administered at levels determined by the patient's clinical situation. Also, while selecting a pharmacological combination between an ACE inhibitor and furosemide or an ARB and furosemide, it is important to consider the adverse effects of the drugs. For instance, it is preferable to combine ARB with Furosemide.
References
Bakri, S. (2005). Deteksi dini dan upaya-upaya pencegahan progresifitas penyaki gagal ginjal kronik. Jurnal Medika Nusantara, 26(3).
Becker, G. J., & Wheeler, D. C. (2010). Blood pressure control in CKD patients: Why do we fail to implement the guidelines? In American Journal of Kidney Diseases (Vol. 55, Issue 3). https://doi.org/10.1053/j.ajkd.2009.12.013
Benedict, M. D., Missmer, S. A., Vahratian, A., Berry, K. F., Vitonis, A. F., Cramer, D. W., & Meeker, J. D. (2011). Secondhand tobacco smoke exposure is associated with increased risk of failed implantation and reduced IVF success. Human Reproduction, 26(9). https://doi.org/10.1093/humrep/der226
Brookes, L. (2004). Hypertension: Pervasive and expensive: New guidelines for management of hypertension in chronic kidney disease. Medscape Cardiology, 8(1).
Budiyanto, C. (2009). Hubungan hipertensi dan diabetes mellitus terhadap gagal ginjal kronik. Kedokteran Islam.
Chobanian, A. V., Bakris, G. L., & Black H.R. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42.
Diniah, M. N., Rachmawati, H., Hasmono, D., & Kusumaningtyas, A. P. (2022). Furosemide use in chronic kidney disease patients. KnE Medicine, 60–74.
Dipiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., & Posey, L. M. (2014). Pharmacotherapy: a pathophysiologic approach (Vol. 4). Appleton and Lange.
Fischer, M. J., & O’Hare, A. M. (2010). Epidemiology of hypertension in the elderly with chronic kidney disease. In Advances in Chronic Kidney Disease (Vol. 17, Issue 4). https://doi.org/10.1053/j.ackd.2010.05.003
Guyton, A. C., & Hall, J. E. (2007). Medical physiology textbook. Elsevier.
Hou, F. F. (2008). Pharmacological intervention of hypertension in proteinuric chronic kidney disease: How and what? Chinese Medical Journal, 121(9). https://doi.org/10.1097/00029330-200805010-00016
Hsieh, M., & Power, D. A. (2009). Abnormal renal function and electrolyte disturbances in older people. In Journal of Pharmacy Practice and Research (Vol. 39, Issue 3). https://doi.org/10.1002/j.2055-2335.2009.tb00460.x
Indonesia’s Ministry of Health. (2013). Riset kesehatan dasar: Riskesdas 2013.
Levey, A. S., Coresh, J., Bolton, K., Culleton, B., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J., Levin, A., Minaker, K. L., Nelson, R., Rennke, H., Steffes, M., Witten, B., Hogg, R. J., Furth, S., Lemley, K. v., … Briggs, J. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. In American Journal of Kidney Diseases (Vol. 39, Issue 2 SUPPL. 1).
Muchid. (2006). Pharmaceutical care untuk pasien penyakit hipertensi. Departemen Kesehatan Indonesia.
Muchid. (2008). Pharmaceutical care untuk pasien penyakit jantung koroner. Departemen Kesehatan Indonesia.
Mycek, M. J., Harvey, R. A., & Champe, P. C. (2001). Farmakologi ulasan bergambar. Widya Medika.
Prakash, S., & O’Hare, A. M. (2009). Interaction of aging and chronic kidney disease. Seminars in Nephrology, 29(5). https://doi.org/10.1016/j.semnephrol.2009.06.006
Tessy, A. (2006). Hipertensi pada penyakit ginjal. In Buku ajar ilmu penyakit dalam (4th ed.). FKUI.
Toto, R. D. (2005). Treatment of hypertension in chronic kidney disease. Seminars in Nephrology, 25(6). https://doi.org/10.1016/j.semnephrol.2005.05.016
Published
Issue
Section
License
Copyright (c) 2023 Hesti Effendi, Helmi Arifin, Nasrul Zubir
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
